Santos DO, Coelho JG, Neri ECL, Campos-Souza IC, Ponte CGG, Antas PRZ. The Differential In Vitro Presentation of Mycobacterium leprae Antigens by Human Dendritic Cells is determined by the Mechanism of Host Cell Adhesion. Journal of Clinical & Cellular Immunology [Internet]. 2016;7(4):1-8. Available from: http://www.arca.fiocruz.br/bitstream/icict/18220/2/paulo2_antas_etal_IOC-2016.pdf

Binns C, Low WY. Leprosy. Asia-Pacific journal of public health [Internet]. 2016;28(7):560-1. Available from: http://journals.sagepub.com/doi/pdf/10.1177/1010539516671035

Luz AR, Moura Vergara R, Mourão MSF, others. Lower limb ulcers. In: Vascular Diseases for the Non-Specialist. Springer; 2017. pp. 203–220.

El Idrissi B. Complement in neuroinflammation : Studies in leprosy and Amyotrophic Lateral Sclerosis [Internet]. Faculty of Medicine (AMC-UvA). [Amsterdam]: University of Amsterdam; 2017. p. 275 p. Available from: http://hdl.handle.net/11245.1/6455df2c-f9a6-403a-8061-7260d7446e3b

Sanclemente, Burgos, Nova, Hernández, González, Reyes, et al. The impact of skin diseases on quality of life: A multicenter study. Actas dermo-sifiliográficas [Internet]. 2017; Available from: http://www.actasdermo.org/en/the-impact-skin-diseases-on/avance-resumen/S0001731016304343/

Mittal S, Rakshith, Misri, Pai S, Shenoy N. Guillain-Barré syndrome: A rare manifestation of Hansen’s disease. Neurology India [Internet]. 2017;65(1):179-80. Available from: http://www.neurologyindia.com/text.asp?2017/65/1/179/198191

Sousa J, Aarão TLS, Rodrigues de Sousa J, Hirai KE, Mota Silva L, Dias LB, et al. Endothelium adhesion molecules ICAM-1, ICAM-2, VCAM-1 and VLA-4 expression in leprosy. Microbial pathogenesis. 2017;

Ura S, Baccarelli R, Marciano L, Teixeira MJ, Virmond M, Raicher I, et al. Neuropathic pain in leprosy: symptom profile characterization and comparison with neuropathic pain of other etiologies. PAIN Reports [Internet]. 2018;:1-7. Available from: https://journals.lww.com/painrpts/Fulltext/2018/04000/Neuropathic_pain_in_leprosy___symptom_profile.4.aspx

CBJM C. Reducing Stigmatisation of Leprosy: What is Being Done? Journal of traditional medicine & clinical naturopathy [Internet]. 2016;(5):194. Available from: https://www.omicsgroup.org/journals/reducing-stigmatisation-of-leprosy-what-is-being-done-.php?aid=81344

Tarique M, Saini C, Naqvi RA, Khanna N, Rao. Increased IL-35 producing Tregs and CD19(+)IL-35(+) cells are associated with disease progression in leprosy patients. Cytokine. 2016;91:82-8.